Medovex, a company that makes products to treat back pain, has been awarded a $760,107 grant from the NSW government to establish a device manufacturing and sterilisation facility at Wollongong. According to an update from the state government on Monday, the funded project will establish a facility for device manufacture and small-batch sterilisation of medical…
Wearable biosensor-based diagnostics company Nutromics has raised $7.5 million in an “acceleration round” led by an unnamed Australian life sciences investor. In a statement on Tuesday, Nutromics said the funds brought the total amount of investment in the company to $60 million, as it progresses commercialisation of its lab-on-a-patch platform, integrating “DNA-based biosensors with microneedles…
A medical innovation accelerator located within Monash Technology Precinct and focussing on cardiovascular, kidney and metabolic disease opened on Wednesday. According to a statement from Monash University, the The Monash Velos Accelerator was assisted through a $17.5 million Victorian Higher Education State Investment Fund grant and “will embed commercialisation capabilities” at the precinct. The accelerator…
The Australian Government announced on Monday it would invest $12 million to develop new Australian-made medical devices and medicine for people with cardiovascular disease and diabetes. Fourteen Australian start-up and innovator companies will receive funding and commercialisation support to develop improved treatment for management of cardiovascular disease and complications of type 1 and 2 diabetes.…
An invention born at RMIT University will go on sale for the first time ever in July, following regulatory approval from the US Food and Drug Administration for an ingestible capsule that can help diagnose gut disorders. According to a statement from RMIT on Monday, Atmo Biosciences’ device has moved “from concept to clinical reality”…
An ingestible capsule used to monitor gut health markers has taken another small step towards commercialisation, with RMIT University transferring IP ownership to Atmo Biosciences. Digital health business Atmo Biosciences is commercialising a capsule that it says “measures gases as it travels through the gastrointestinal tract and transmits the data wirelessly” and which was first…
The first Australian implant of a Total Artificial Heart (TAH) made by BiVACOR – founded by Australian inventor Dr Daniel Timms – was an “unmitigated clinical success”, according to the Artificial Heart Frontiers Program (AHFP.) The Artificial Heart Frontiers Program, led by Monash University, said on Wednesday that an unnamed Australian received the implant on…
Breakthrough Victoria has invested $800,000 in Diag-Nose.io Medical (DNM), a Melbourne-based innovator in respiratory healthcare, to enhance clinical management and drug discovery for chronic respiratory diseases globally. Originally launched from Stanford’s ENT Innovation Program and now headquartered in Notting Hill, Melbourne, Diag-Nose.io is revolutionising the treatment of chronic respiratory diseases (CRDs) like asthma and COPD,…
Radiopharmaceutical medical imaging manufacturer Cyclopharm has revealed a possible new use for its Technegas system – for evaluating the progress of lung transplantation. The use is detailed in a US-based study which highlights the clinical utility and operational benefits of the Technegas technology compared to current US ventilation imaging radiopharmaceuticals used in lung transplant evaluation.…
Drug manufacturer AstraZeneca has ordered four more APAS Independence laboratory instruments from AI microbiology automation manufacturer Clever Culture Systems, formally known as LBT Innovations. The order, worth $3.1 million over seven years, adds to the five APAS instruments already in use by the global pharmaceutical company, where they monitor for bacterial contamination in the company’s…